Specifications - Abbott Laboratories Biotech Facility Barceloneta, Puerto Rico

Key Data
Order year	2002
Project type	Biologics facility
Output chemicals	Humira (adalimumab) (CAT-derived human anti-TNFα [tumour necrosis factor α]) monoclonal antibody
Location	Barceloneta, Commonwealth of Puerto Rico
Estimated investment	$450m
Construction started	2003
Completion	2005 (then validation took until April 2007)
Key Players
Sponsors	Abbott Laboratories, Abbott Biotechnology Ltd
General contractor	Insulation Specialties, Pharmabio, Cives Steel Company Corp, Industrial Sprinklers
Engineering	LG Scott
Financing	Abbott Laboratories and tax incentives from the Government of the Commonwealth of Puerto Rico